{"id":"rinexin-tab","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Rinexin works by blocking the action of angiotensin II, a potent vasoconstrictor, thereby reducing blood pressure and alleviating symptoms of hypertension.","oneSentence":"Rinexin is a small molecule that inhibits the renin-angiotensin system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:52:28.186Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT03318276","phase":"PHASE3","title":"Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2017-02-20","conditions":"Peripheral Arterial Disease","enrollment":170}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo (For SID142)"],"phase":"phase_3","status":"active","brandName":"Rinexin® Tab","genericName":"Rinexin® Tab","companyName":"SK Chemicals Co., Ltd.","companyId":"sk-chemicals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rinexin is a small molecule that inhibits the renin-angiotensin system. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}